Valerio José E, de Jesús Aguirre Vera Guillermo, Zumaeta Jorge, Rea Noe Santiago, Fernandez Gomez Maria P, Mantilla-Farfan Penelope, Valente Laurel, Alvarez-Pinzon Andrés M
Neurosurgery Department, Latinoamerica Valerio Foundation, Weston, FL, 33331, USA.
Department of Neurological Surgery, Palmetto General Hospital, Miami, FL 33016, USA.
Biomedicines. 2025 May 10;13(5):1161. doi: 10.3390/biomedicines13051161.
5-Aminolevulinic acid (5-ALA) serves as a precursor in the heme biosynthesis pathway, resulting in the selective accumulation of protoporphyrin IX (PpIX) within glioma cells. This property facilitates fluorescence-guided resection (FGR) in high-grade gliomas (HGGs), enhancing surgical precision and oncological results. Nonetheless, its clinical implementation is restricted by factors such as accessibility, cost, and technical limitations. A systematic review of PubMed literature (2019-2024) was conducted to assess the efficacy of 5-ALA in HGG surgery compared to conventional white light microscopy. Studies focusing on non-neurosurgical applications, pediatric populations, and non-HGG indications were excluded. Nineteen articles met the criteria. Recent studies indicate that 5-ALA-guided resection significantly enhances gross total resection (GTR) rates compared to white light surgery (75.4% vs. 54.3%, < 0.001). Patients receiving 5-ALA-assisted resection exhibit enhanced progression-free survival (PFS) at 6 months (median 8.1 months compared to 5.4 months, = 0.002) and overall survival (OS) (median 15.2 months versus 12.3 months, = 0.008). The necessity for specialized neurosurgical microscopes equipped with blue light filters restricts accessibility, especially in low-resource environments. Recent advancements in fluorescence-enhancing technologies, particularly loupe-based systems, have demonstrated increases in fluorescence intensity by up to tenfold through direct emission. Sodium fluorescein, originally designed for ophthalmological use, has been adapted for enhancing contrast in intracranial tumors; however, its non-specific binding to serum albumin restricts its accuracy in glioma resection. Recent publications demonstrate that 5-ALA fluorescence-guided surgery significantly improves gross total resection rates and survival outcomes in patients with high-grade gliomas. Although it offers clinical advantages, cost and equipment constraints continue to pose substantial obstacles to broad implementation. Additional research is required to enhance fluorescence-guided techniques and increase accessibility in resource-constrained environments.
5-氨基乙酰丙酸(5-ALA)是血红素生物合成途径中的一种前体,可导致胶质瘤细胞内原卟啉IX(PpIX)的选择性积累。这一特性有助于高级别胶质瘤(HGG)的荧光引导切除术(FGR),提高手术精度和肿瘤治疗效果。尽管如此,其临床应用受到可及性、成本和技术限制等因素的制约。对PubMed文献(2019 - 2024年)进行了系统综述,以评估5-ALA在HGG手术中与传统白光显微镜相比的疗效。排除了关注非神经外科应用、儿科人群和非HGG适应症的研究。19篇文章符合标准。近期研究表明,与白光手术相比,5-ALA引导的切除术显著提高了全切除率(GTR)(75.4%对54.3%,<0.001)。接受5-ALA辅助切除术的患者在6个月时无进展生存期(PFS)延长(中位值8.1个月对5.4个月,=0.002),总生存期(OS)也延长(中位值15.2个月对12.3个月,=0.008)。配备蓝光滤光片的专用神经外科显微镜的必要性限制了其可及性,尤其是在资源匮乏的环境中。荧光增强技术的最新进展,特别是基于放大镜的系统,通过直接发射已证明荧光强度可提高多达十倍。最初用于眼科的荧光素钠已被用于增强颅内肿瘤的对比度;然而,其与血清白蛋白的非特异性结合限制了其在胶质瘤切除术中的准确性。近期出版物表明,5-ALA荧光引导手术显著提高了高级别胶质瘤患者的全切除率和生存结果。尽管它具有临床优势,但成本和设备限制仍然是广泛应用的重大障碍。需要进一步研究以改进荧光引导技术,并提高在资源有限环境中的可及性。